This 2016 instructional course lecture reviews the full spectrum of management for end-stage tibiotalar arthritis — from nonsurgical options through five distinct arthrodesis techniques — with a particular focus on identifying when total ankle arthroplasty is not appropriate and how to choose among fusion strategies based on deformity, bone quality, and soft-tissue status.
When a patient with end-stage ankle arthritis fails nonsurgical management, tailor your surgical approach to their deformity profile: choose less invasive arthrodesis (arthroscopic or miniarthrotomy) for non-deformed ankles with compromised soft tissue, reserve extensile open techniques for coronal malalignment >15° or anterior talar subluxation, and approach TAA with caution — long-term implant survival data are sobering, and patient selection (excluding infection, Charcot, osteonecrosis, severe deformity, insensate foot) is paramount.
This 2016 instructional course lecture reviews the full spectrum of management for end-stage tibiotalar arthritis — from nonsurgical options through five distinct arthrodesis techniques — with a particular focus on identifying when total ankle arthroplasty is not appropriate and how to choose among fusion strategies based on deformity, bone quality, and soft-tissue status.
When a patient with end-stage ankle arthritis fails nonsurgical management, tailor your surgical approach to their deformity profile: choose less invasive arthrodesis (arthroscopic or miniarthrotomy) for non-deformed ankles with compromised soft tissue, reserve extensile open techniques for coronal malalignment >15° or anterior talar subluxation, and approach TAA with caution — long-term implant survival data are sobering, and patient selection (excluding infection, Charcot, osteonecrosis, severe deformity, insensate foot) is paramount.